
Share
17th December 2018
12:43pm GMT

221 women were affected by the CervicalCheck controversy which saw false negative results delivered to patients under the national screening programme. Among them was Vicky Phelan who settled a High Court case against the HSE and one of the laboratories used, Clinical Pathology Laboratories (CPL), earlier this year. The Irish Times reported that 43-year-old Vicky "initially paid out of her own pocket for Pembrolizumab, which costs €8,500 per infusion every three weeks."This is the best Christmas present I could get this year. Thank you to @alankellylabour and @ClaireByrneLive for working with me on this. Thank you @SimonHarrisTD and Prof Barry for making this happen. https://t.co/UQHlIrHVso
— Vicky Phelan (@PhelanVicky) December 15, 2018
Pembrolizumab significantly reduced the size of her tumours and earlier this month the mum of two said:
"I am evidence that this drug works."Mr Harris told RTÉ:
"I’ve spoken to Michael this morning and they hope to be in a position to make this drug available to all women with cervical cancer for whom it’s clinically suitable very shortly."Vicky is due to speak on the Claire Byrne show at 10:35 pm on RTÉ One tonight.
Explore more on these topics: